PROCEPT BioRobotics Corporation
PRCT
$25.79
$0.110.43%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 37.22% | 50.07% | 55.71% | 59.36% | 64.84% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 37.22% | 50.07% | 55.71% | 59.36% | 64.84% |
| Cost of Revenue | 27.95% | 24.85% | 23.18% | 27.72% | 34.17% |
| Gross Profit | 43.13% | 68.80% | 82.62% | 86.89% | 92.96% |
| SG&A Expenses | 33.48% | 37.27% | 35.36% | 32.41% | 30.09% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 28.28% | 28.12% | 28.12% | 30.50% | 30.87% |
| Operating Income | -7.50% | 13.09% | 16.31% | 11.10% | 11.50% |
| Income Before Tax | -4.76% | 15.84% | 19.22% | 13.10% | 14.02% |
| Income Tax Expenses | -48.37% | -- | -- | -- | -- |
| Earnings from Continuing Operations | -4.55% | 15.47% | 18.86% | 12.75% | 13.68% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4.55% | 15.47% | 18.86% | 12.75% | 13.68% |
| EBIT | -7.50% | 13.09% | 16.31% | 11.10% | 11.50% |
| EBITDA | -6.66% | 14.77% | 18.03% | 12.82% | 13.27% |
| EPS Basic | 2.21% | 21.23% | 24.37% | 19.88% | 21.67% |
| Normalized Basic EPS | 2.01% | 21.57% | 24.70% | 20.19% | 21.97% |
| EPS Diluted | 2.21% | 21.23% | 24.37% | 19.88% | 21.67% |
| Normalized Diluted EPS | 2.01% | 21.57% | 24.70% | 20.19% | 21.97% |
| Average Basic Shares Outstanding | 6.56% | 7.16% | 7.28% | 8.88% | 10.24% |
| Average Diluted Shares Outstanding | 6.56% | 7.16% | 7.28% | 8.88% | 10.24% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |